Kallikrein-kinin in infection and cancer - PubMed (original) (raw)
Review
Kallikrein-kinin in infection and cancer
H Maeda et al. Immunopharmacology. 1999 Sep.
Abstract
This review article describes the mechanism of enhancement of vascular permeability in infectious disease and cancer. This phenomenon is primarily mediated by bradykinin, nitric oxide and other unique vascular mediators. They are highly intermingled with each other in these disease states. Furthermore, these mediators are elicited in various in vivo settings most frequently induced by bacterial proteases, and indirect or direct activation of kallikrein-kinin cascade at one or more steps. The key steps involve bacterial proteases or cellular components including lipopolysaccharides. Thus, the use of appropriate protease inhibitors or antagonists, or scavengers in the case of nitric oxide, superoxide or peroxynitrite, are anticipated to attenuate the clinical manifestation induced by such mediators. It also explained that fluid accumulation in ascitic or pleural compartments in the case of carcinomatosis in terminal cancer patients can be largely attributed to bradykinin or related mechanism. Systemic bacterial dissemination is also facilitated by bradykinin, or suppressed by kinin antagonists as well as by the inhibition of kinin production, respectively. Thus, control of the level of such vascular mediators appears important both in infectious disease and in cancer. alpha1-Protease inhibitor, which inhibits neutrophil elastase, is inactivated by oxidative metabolites such as superoxide and peroxynitrite, and this effect activates matrix metalloproteinases. This indicates that oxidative stress activates proteolytic potential, and thus accelerates the degenerative process upon infection.
Similar articles
- Bradykinin and nitric oxide in infectious disease and cancer.
Maeda H, Akaike T, Wu J, Noguchi Y, Sakata Y. Maeda H, et al. Immunopharmacology. 1996 Jun;33(1-3):222-30. doi: 10.1016/0162-3109(96)00063-x. Immunopharmacology. 1996. PMID: 8856154 Review. - Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases.
Wu J, Akaike T, Hayashida K, Okamoto T, Okuyama A, Maeda H. Wu J, et al. Jpn J Cancer Res. 2001 Apr;92(4):439-51. doi: 10.1111/j.1349-7006.2001.tb01114.x. Jpn J Cancer Res. 2001. PMID: 11346467 Free PMC article. - Pleiotropic effects of a vibrio extracellular protease on the activation of contact system.
Park JE, Park JW, Lee W, Lee JS. Park JE, et al. Biochem Biophys Res Commun. 2014 Jul 25;450(2):1099-103. doi: 10.1016/j.bbrc.2014.06.121. Epub 2014 Jul 1. Biochem Biophys Res Commun. 2014. PMID: 24996182 - Pharmacological characterization of rabbit corpus cavernosum relaxation mediated by the tissue kallikrein-kinin system.
Lopes-Martins RA, Antunes E, Oliva ML, Sampaio CA, Burton J, de Nucci G. Lopes-Martins RA, et al. Br J Pharmacol. 1994 Sep;113(1):81-6. doi: 10.1111/j.1476-5381.1994.tb16177.x. Br J Pharmacol. 1994. PMID: 7529116 Free PMC article. - The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect.
Maeda H. Maeda H. Cancer Sci. 2013 Jul;104(7):779-89. doi: 10.1111/cas.12152. Epub 2013 Apr 22. Cancer Sci. 2013. PMID: 23495730 Free PMC article. Review.
Cited by
- Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.
Makimoto A, Fang J, Maeda H. Makimoto A, et al. Cancers (Basel). 2021 Jul 23;13(15):3698. doi: 10.3390/cancers13153698. Cancers (Basel). 2021. PMID: 34359599 Free PMC article. Review. - Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways.
Wang W, Zhou Y, Wei R, Jiang G, Li F, Chen X, Wang X, Ma D, Xi L. Wang W, et al. Oncol Rep. 2019 Dec;42(6):2521-2527. doi: 10.3892/or.2019.7380. Epub 2019 Oct 18. Oncol Rep. 2019. PMID: 31638249 Free PMC article. - Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura Y, Mochida A, Choyke PL, Kobayashi H. Nakamura Y, et al. Bioconjug Chem. 2016 Oct 19;27(10):2225-2238. doi: 10.1021/acs.bioconjchem.6b00437. Epub 2016 Sep 2. Bioconjug Chem. 2016. PMID: 27547843 Free PMC article. Review. - Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.
Bazak R, Houri M, Achy SE, Hussein W, Refaat T. Bazak R, et al. Mol Clin Oncol. 2014 Nov;2(6):904-908. doi: 10.3892/mco.2014.356. Epub 2014 Jul 23. Mol Clin Oncol. 2014. PMID: 25279172 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical